Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Experts and Policymakers Demand Changes to the Current Approach to Asthma Management

20.10.2006
Trend and direction of asthma therapy viewed as incorrect and not reflective of current medical knowledge

Clinical and regulatory changes must be made to asthma management to ensure it reflects current scientific understanding of the disease, and the needs of patients, say asthma experts. These conclusions form part of the ‘Brussels Declaration’, defining changes that need to be made in order to improve outcomes for asthma patients, developed by leading asthma experts, together with EU policymakers, regulators and patient groups attending the ‘Summit for Change in Asthma Management’, which took place at the EU Parliament on 18th and 19th October 2006.

Key areas for action identified during the Summit, hosted by Liberal Democrat MEP, Liz Lynne (UK) and co-chaired by leading asthma expert Professor Stephen Holgate of the University of Southampton (UK) include: a rapid need to update national and international clinical guidelines on the treatment of asthma, including the EMEA Guidance Note on Asthma; ensure all patients and professionals fully understand the current thinking behind asthma management; inclusion of wider measures of asthma control in studies and practice, which take into account patient quality of life. In addition, the EU Parliament was encouraged with making asthma, its research and its management a political priority through mechanisms such as the European Parliament Initiative Report.

Professor Holgate defines the Summit and the resulting Declaration as a great step forward for asthma management and patients: “This meeting has been extremely valuable as it has allowed health care professionals, scientists and patient groups to work directly with regulators and policymakers to establish where and how improvements need to be made in order for asthma patients to receive optimum treatment. However, our work does not end here; it is vital that all of the actions agreed upon are also acted upon to ensure asthma patients benefit fully.”

Current Thinking

During the Summit various clinicians presented information which showed asthma to be a systemic inflammatory disease which affects more than just the lungs and thus the need to control inflammation is essential. However, current guidelines and practice are based on a historical view of diagnosis and treatment of asthma which only measure airflow in the lungs and so may not truly capture whether the inflammation is under control or whether other parts of the body are affected by the same type of inflammation. Furthermore, data also shows that patients respond differently to treatments and one option may not suit all. Therefore treatment should be individualised to meet the needs of the patient. Unfortunately, current methods of assessing therapies that influence the wider aspects of allergic inflammation are not reflected in guidelines which currently are restrictive in their recommendations and limit the choice of treatments available for clinicians to choose from.

The Cost of Asthma

It is estimated that over 30 million people in Europe have asthma and the number is rising.1 In addition, deaths from asthma have reached 180,000 annually 2 and the economic cost of asthma in Europe is thought to be in the region of €17 billion per year with an annual productivity loss estimated at €9.8bn.3 The economic and social costs of asthma are largely due to uncontrolled disease, and are likely to rise as its prevalence, complexity and severity increases4 and therefore improvement in disease control would substantially reduce costs.

Rosie Allan | alfa
Further information:
http://www.hillandknowlton.com

More articles from Health and Medicine:

nachricht 3D images of cancer cells in the body: Medical physicists from Halle present new method
16.05.2018 | Martin-Luther-Universität Halle-Wittenberg

nachricht Better equipped in the fight against lung cancer
16.05.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

Im Focus: Dozens of binaries from Milky Way's globular clusters could be detectable by LISA

Next-generation gravitational wave detector in space will complement LIGO on Earth

The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...

Im Focus: Entangled atoms shine in unison

A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.

The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...

Im Focus: Computer-Designed Customized Regenerative Heart Valves

Cardiovascular tissue engineering aims to treat heart disease with prostheses that grow and regenerate. Now, researchers from the University of Zurich, the Technical University Eindhoven and the Charité Berlin have successfully implanted regenerative heart valves, designed with the aid of computer simulations, into sheep for the first time.

Producing living tissue or organs based on human cells is one of the main research fields in regenerative medicine. Tissue engineering, which involves growing...

Im Focus: Light-induced superconductivity under high pressure

A team of scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg investigated optically-induced superconductivity in the alkali-doped fulleride K3C60under high external pressures. This study allowed, on one hand, to uniquely assess the nature of the transient state as a superconducting phase. In addition, it unveiled the possibility to induce superconductivity in K3C60 at temperatures far above the -170 degrees Celsius hypothesized previously, and rather all the way to room temperature. The paper by Cantaluppi et al has been published in Nature Physics.

Unlike ordinary metals, superconductors have the unique capability of transporting electrical currents without any loss. Nowadays, their technological...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

 
Latest News

Supersonic waves may help electronics beat the heat

18.05.2018 | Power and Electrical Engineering

Keeping a Close Eye on Ice Loss

18.05.2018 | Information Technology

CrowdWater: An App for Flood Research

18.05.2018 | Information Technology

VideoLinks
Science & Research
Overview of more VideoLinks >>>